Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Cancers|May 11, 2024
High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center ExperienceLewis F Nasr, Marianne Zoghbi, Rossana Lazcano, et al.International Journal of Cancer|February 7, 2022
Real-world use of palbociclib monotherapy in retroperitoneal liposarcomas at a large volume sarcoma centerElise F Nassif, Brandon Cope, Raymond Traweek, et al.Biorxiv : the Preprint Server for Biology|June 5, 2026
Spatially-Resolved Multiomic Atlas of Leiomyosarcoma Identifies Two Clinically Relevant Epigenetically-Driven Cell StatesRyan A Denu, Zhao Zheng, Yingda Jiang, et al.Frontiers in Immunology|May 15, 2025
Dedifferentiated liposarcomas treated with immune checkpoint blockade: the MD Anderson experienceMadeline B Torres, Cheuk Hong Leung, Marianne Zoghbi, et al.The Lancet. Oncology|August 7, 2022
Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trialNeeta Somaiah, Anthony P Conley, Edwin Roger Parra, et al.Biorxiv : the Preprint Server for Biology|April 3, 2026
Spatially-resolved single cell atlas of liposarcoma reveals lineage hierarchies, immune niches, and regulatory circuitsRyan A Denu, Veena Kochat, Zhao Zheng, et al.Frontiers in Oncology|October 31, 2022
The immune landscape of undifferentiated pleomorphic sarcomaRossana Lazcano, Carmelia M Barreto, Ruth Salazar, et al.JAMA Oncology|February 26, 2026
Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 MutationsAndrea Napolitano, Heikki Joensuu, Sara Rothschild, et al.Nature Cancer|February 13, 2024
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcomaChristina L Roland, Elise F Nassif Haddad, Emily Z Keung, et al.Pageof 4